Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.
1 个月
Bloomberg on MSNBristol Raises Guidance on Demand for Eliquis, New Drugsraised its 2024 earnings guidance after reporting better-than-expected revenue and profit, fueled by demand for the ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果